Poland· PL-100295794
NexoBrid
A bromelains product containing koncentrat enzymów proteolitycznych wzbogaconych w bromelainę, registered in Poland by MediWound Germany GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Bromelains is registered in 11 of 19 countries.
Countries holding a registration under ATC D03BA03 (bromelains), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Bromelains · ATC D03BA03
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Koncentrat enzymów proteolitycznych wzbogaconych w bromelainę
- Manufacturer
- MediWound Germany GmbH
- Country
- Poland (PL)
- ATC code
- D03BA03
- ATC class
- Bromelains
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991050566
- gtin07290012699122
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bromelains in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyBromelain-PosUrsapharm Arzneimittel Gmbh
- United KingdomBackOsamine tabletsOptima Consumer Health Ltd
- SpainNEXOBRID 2 g polvo y gel para gelMediwound Germany Gmbh
- SwedenNexoBrid 2 g Pulver och gel till gelMediWound Germany GmbH
- CzechiaNEXOBRIDMediWound Germany GmbH, Rüsselsheim
- BelgiumNexobrid 2 gMediwound Germany
- NorwayNexoBridMediWound Germany GmbH
- SwitzerlandNexoBrid, poudre et gel pour gelTriskel INTEGRATED SERVICES SA
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Bromelain-Pos, Bromelaintabletten Hysan
- Iceland · Nexobrid
- Liechtenstein · Nexobrid
- Norway · Nexobrid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7151e7d-7a9d-4d89-bd75-9b65d1e193e9 GET /v1/drugs/d7151e7d-7a9d-4d89-bd75-9b65d1e193e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i podłoże żelowe do sporządzania żelu",
"source": "urpl",
"strength": "2 g",
"packaging": "05909991050566 ¦ Rpz ¦ Skasowane ¦ 83240\n1 fiolka 2 g proszku + 1 butelka 20 g z podłożem żelowym\n07290012699122 ¦ Rpz ¦ EU/1/12/803/001 ¦ 107161\n1 fiol. 2 g proszku + 1 butelka 20 g z podłożem żelowym",
"substance": null,
"common_name": "Koncentrat enzymów proteolitycznych wzbogaconych w bromelainę",
"pl_product_id": "100295794",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about bromelains.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.